Canadian Sec - Delayed Quote CAD

Optimi Health Corp. (OPTI.CN)

Compare
0.2100 -0.0050 (-2.33%)
At close: November 1 at 1:43 p.m. EDT
Loading Chart for OPTI.CN
DELL
  • Previous Close 0.2150
  • Open 0.2200
  • Bid 0.2100 x --
  • Ask 0.2150 x --
  • Day's Range 0.2050 - 0.2200
  • 52 Week Range 0.1500 - 0.5800
  • Volume 25,780
  • Avg. Volume 55,012
  • Market Cap (intraday) 19.879M
  • Beta (5Y Monthly) 1.28
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0600
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Optimi Health Corp. engages in the research, cultivation, processing, extraction, and distribution of psilocybin, psilocin, other psychedelic substances, and functional mushrooms for health and wellness markets in Canada and internationally. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of fungi varieties, including Lion's Mane, Chaga, Reishi, Turkey Tail, and Cordyceps. It sells its products through www.optimilife.com, an e-commerce website platform; and Amazon marketplace, and distributors/brokers. The company was formerly known as 1251418 BC Ltd. and changed its name to Optimi Health Corp. in August 2020. Optimi Health Corp. was incorporated in 2020 and is based in Garibaldi Highlands, Canada.

www.optimihealth.ca

--

Full Time Employees

September 30

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

Recent News: OPTI.CN

View More

Performance Overview: OPTI.CN

Trailing total returns as of 2024-11-01, which may include dividends or other distributions. Benchmark is

.

YTD Return

OPTI.CN
14.29%
S&P/TSX Composite index
15.73%

1-Year Return

OPTI.CN
23.53%
S&P/TSX Composite index
28.51%

3-Year Return

OPTI.CN
66.67%
S&P/TSX Composite index
15.30%

5-Year Return

OPTI.CN
73.75%
S&P/TSX Composite index
33.10%

Compare To: OPTI.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: OPTI.CN

View More

Valuation Measures

As of 2024-11-01
  • Market Cap

    19.88M

  • Enterprise Value

    22.27M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    75.27

  • Price/Book (mrq)

    1.77

  • Enterprise Value/Revenue

    88.60

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -21.27%

  • Return on Equity (ttm)

    -45.46%

  • Revenue (ttm)

    351.92k

  • Net Income Avi to Common (ttm)

    -5.64M

  • Diluted EPS (ttm)

    -0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    245.84k

  • Total Debt/Equity (mrq)

    25.26%

  • Levered Free Cash Flow (ttm)

    -3.1M

People Also Watch